Jack Miller Email & Phone Number

Montreal

Independent consultant providing Sales, Marketing and Business Development services to companies in the fields of pharmaceutical therapeutics, diagnostics, human and veterinary ophthalmic, environmentally green products, managed health care services and diabetes management and educational services. Accomplishments include;1. Led the development of ophthalmic diagnostic device from inception to final prototype to licensing negotiations in under 9 months2. Developed and implemented business development plan for a line of organic, biodegradable, phosphate free cleansers. Negotiated with multiple distributors for market representation.3. Developed Web 2.0 business development strategy for a health care management company4. Developed, implemented an alternate Phase III/IV clinical trial strategy for Oral AIDS product and now negotiating licensing agreement5. Developed GlucoAid Diabetes Smart Phone Application business as a market and clinical research data mining vehicle6. Concluded out-licensing of novel eye drops into the USA7. Developed an alternate strategy for oral diabetes therapy to include the pet food market with an innovative manufacturer-veterinarian-pet owner loyalty affinity program

Montreal

-Developed patent strategy-Developed and initiated international distribution strategy-Initiated independent sales agent network

Vancouver/Montreal

Senior Vice President and Director – Forbes Medi-Tech Inc.Forbes Medi-Tech is an operating pharmaceutical product development company focused on the cardiovascular and steroid markets. The lead compound is based on phytosterol extraction technology licensed from UBC.Initial involvement as a consultant until 1995 and then full time participant in the senior management team to develop the strategies and business relationships that drove the company forward. These included among many other responsibilities;-1. Negotiated and oversaw the pilot production development at Slovakofarma (Slovakia), which resulted in the necessary product and initial proof of concept to attract Novartis to a licensing agreement.2. Negotiated with Novartis to out-license the lead compound (Phytrol) and obtain licensing, milestone and royalty fees in excess of US$ 10 million.3. Negotiated and developed the steroid production up-scaling.4. Identified and acquired the Canadian pilot facility and managed the refurbishment to develop larger scale production capacity and thereby satisfying the licensing conditions which generated milestone payments. The facility was refurbished on a fast track schedule in under 5 months and within a $3.4 million budget.5. Negotiated to acquire technology and a supply agreement with BC Chemicals.6. Negotiated with Cargill to supply phytosterol raw materials. Long term stable contract during period of rapidly increasing world demand.7. Identified and developed the business relationship with a strategic partner to build an economical 1000 metric ton production facility. Costs were reduced from $150/kilo in the initial pilot facility to $7/kilo in the current operating facility. 8. Responsible for transferring production to the new facility and arranging for the sale of the pilot plant.9. Active participation in several rounds of company financing which raised $75 million.

Montreal, Canada Area

VP & General Manager, Sales technologies Inc. (a division of Dun & Bradstreet)Sales Technologies is an Atlanta based company providing pharmaceutical sales force automation services and hardware support.• Established the Canadian subsidiary to provide pharmaceutical sales force automation services.• Established sales organization and achieved a 60% market share of sales force automation software installations within 2 years.• Successfully introduced 3 new products for the pharmaceutical industry with one being developed in Canada. • Used Canadian developed software to penetrate into other industry sectors.• Salvaged a major dissatisfied customer avoiding a US$ 570,000 refund by migrating them to the locally developed new product. The client was satisfied and became referencable.

Montreal, Canada Area

IMS is a worldwide company providing secondary market research and sales management information to the pharmaceutical industry,• As Director of Marketing, expanded department from 3 to 10 people and assumed full profit and loss responsibilities as well as production. • Developed sales and service organization and managed sales and profit growth of 45%. • Planned and orchestrated the cannibalization of a manual service with sales of $350,000 by a computer based technology which realized sales of $500,000 in the first year. This new service was generating revenues of approximately $7 million by 1991.• Directed the development of TSA starting with sales of $1 million from 14 clients to revenues exceeding $10 million with a client base of 45 companies. • Developed local TSA production capabilities with a production and client services staff of 60 people in Montreal and Toronto offices.• Increased quality and client satisfaction while reducing delivery from an average of 45 days to less then 18. • This division consistently increased sales and profit margin growth by over 20% per year and never had a single client cancellation.• Developed on-line information services which grew to generate 30% of total revenue.• Developed 5 year strategic business development program in with clients and data suppliers to release sales information at the account level. This contributed to 20% profit margins and was accomplished without allowing any competitive inroads into the market.

Master Of Business Administration (Mba), Marketing & Business Development

Phd(Abd), Msc, Human Genetics And Human Biochemical Genetics